Stem cell therapy Queen Creek: what can help your joint?

What does the soreness tell you?

Notice which activity brings on your soreness. Also notice whether rest calms it. Don't ignore an ache that stays during rest.

Watch which task has become hard. Your knee may resist stairs or longer walks. Your shoulder may hurt while lifting or sleeping.

What can you try at home?

Keep moving, but ease the strain for now. Try a shorter walk or fewer games. Stop when the pain turns sharp.

Gentle strength work may support your sore joint. Braces and canes aren't right for everyone. Don't add medicine until your doctor checks your current drugs.

What can QC Kinetix offer?

QC Kinetix uses regenerative treatments as its name for office joint care that begins with a blood or marrow draw. The medical provider is the person who examines you first. You'll hear what each procedure involves before choosing.

The letters PRP stand for platelet-rich plasma. The clinic draws your blood, then spins it so platelets collect in less plasma. It'll place that plasma into your sore joint.

Concentrated PRP also needs drawing and spinning blood. Natural pain treatments and joint preservation are broad clinic terms. Ask if they mean a blood procedure, a marrow procedure, or care before knee or hip surgery.

When shouldn't you wait?

Get quick help when fever comes with swelling. Don't wait if a joint looks misshapen after a fall. Sudden loss of weight-bearing also needs urgent care.

Routine soreness can be checked at the Chandler clinic. It isn't an emergency room or hospital. Banner Ironwood on Gantzel Road provides hospital care.

Sources

1. A CDC public health investigation confirmed culture-positive bacterial infections in 20 patients who received umbilical cord blood-derived products marketed as stem cell treatment between August 2017 and September 2018; whole-genome sequencing matched patient isolates to the product.

   Hartnett KP, et al. — Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood-Derived Products Marketed as Stem Cell Therapies. JAMA Netw Open, 2021. DOI: 10.1001/jamanetworkopen.2021.28615.

2. A retrospective comparison of 523 bone marrow aspiration procedures against 435 open iliac crest bone graft harvests found aspiration significantly reduced complications - relevant because marrow aspiration for a joint injection is a real procedure with a real, if low, complication rate.

   Hernigou P, et al. — Morbidity of graft harvesting versus bone marrow aspiration in cell regenerative therapy. Int Orthop, 2014. DOI: 10.1007/s00264-014-2318-x.

3. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.

4. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

5. Three patients who received intravitreal injections of autologous adipose-derived 'stem cells' at a US clinic for macular degeneration suffered severe bilateral vision loss; pre-injection acuity ranged from 20/30 to 20/200 and one year later ranged from 20/200 to no light perception.

   Kuriyan AE, et al. — Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD. N Engl J Med, 2017. DOI: 10.1056/NEJMoa1609583.

6. A comprehensive review of published case reports, clinical reports and media accounts catalogued the safety incidents associated with unproven stem cell interventions and the factors driving the global growth of the 'stem cell tourism' market.

   Bauer G, et al. — Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Stem Cells Transl Med, 2018. DOI: 10.1002/sctm.17-0282.

7. A phase I single-arm study of 10 patients with chronic discogenic low back pain found a single intradiscal injection of adipose-derived MSCs with hyaluronic acid produced no procedure-related or cell-related adverse events over 12 months - a safety signal in 10 people, not an efficacy result.

   Kumar H, et al. — Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study. Stem Cell Res Ther, 2017. DOI: 10.1186/s13287-017-0710-3.

8. A 2025 meta-analysis of 73 double-blind placebo-controlled injection trials in 5,895 knee osteoarthritis patients found placebo responder rates above 50 percent at 1, 3 and 6 months, declining by 12 months - which is why any uncontrolled 'our patients improved' claim from a clinic is uninterpretable.

   Previtali D, et al. — Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Rev, 2025. DOI: 10.1530/EOR-2025-0022.